The story of our birth

Nuvo was born in 2014 at the same time as my third child. My wife was 37 weeks pregnant and became high risk. We suffered a lot of stress because of outdated pregnancy monitoring and medical practice. Thankfully, our baby was born healthy, but the experience left me with a burning desire to offer parents a more complete sense of their journey and reinvent pregnancy monitoring from the ground up. At that moment, I suddenly realized there had to be a better way to help free women from the wall and the worry. That’s why today Nuvo is driven by this vision, using the best technology available.
Oren Oz
NuvoTM Founder

Our team

Meet the pioneers with a passion for transforming pregnancy care.

The Leadership Team

Oren Oz
Founder and CEO
Oren is the CEO and Founder of NuvoTM. A data scientist, entrepreneur and dad, the company was inspired by his wife’s experience during pregnancy. Before NuvoTM, Oren started and led a variety of entrepreneurial ventures, primarily in technology.
Debra Bass
Global CMO and President, United States
Debra leads global development of the NuvoTM corporate brand and the introduction of the company’s innovative technology platform to the U.S. market. Previously, Debra was President, Global Marketing Services at Johnson & Johnson Consumer Companies.
Eran Schindler
Chief Financial Officer
Eran has extensive experience in providing financial and management services to growing high-tech companies. He has supported Initial Public Offerings on Nasdaq and the Tel Aviv Stock Exchange.
Amit Reches
Chief Technology Officer
Amit leads algorithms, data science, machine learning, hardware and clinical affairs activities at NuvoTM. He is a seasoned research and development executive with over 15 years of experience in the medical device domain.
Idan Lazar
Vice President, Operations
Idan leads the global operations and service team, preparing for the mass production of medical devices within the NuvoTM platform. He has over 15 years of experience in manufacturing, with a focus on medical devices.
Orly Hirsch
Vice President, People
Orly focuses on every aspect of the people at NuvoTM to create an employee experience that will achieve success. She has extensive experience driving and facilitating organizational growth and transformation in global, multicultural business environments, as well as startup organizations.
Amit Hasson
Vice President, Software Engineering
Amit leads Nuvo's Cloud and Software Solutions Unit, covering architecture, development and delivery of connected-health solutions. Amit has extensive experience in leading enterprise scale R&D organizations and building products from concept to deployment.
Dotan Raviv
Vice President, Program Management
Dotan leads the Program Management Department, dedicated to executing the Nuvo company vision. Previously, Dotan led a variety of projects in the technology sector, ranging from small systems to mega-system projects.
Noah Klein
Vice President, Business Development
Noah leads Nuvo's Business Development from the Israel corporate headquarters, developing and focusing Nuvo's commercial strategies and helping bring to initial execution. He has experience in startups, enterprise sales, and product-market strategy.

The Board of Directors

Oren Oz
Founder and CEO

Oren is the CEO and Founder of NuvoTM. A data scientist, entrepreneur and dad, the company was inspired by his wife’s experience during pregnancy. Before NuvoTM, Oren started and led a variety of entrepreneurial ventures, primarily in technology.

Gerald M. Ostrov, MBA

Gerald previously served as Chairman & Chief Executive Officer of Bausch & Lomb, Inc., Group Chairman of Johnson & Johnson, and President of CIBA Consumer Pharmaceuticals.

Deb Henretta

Deb has spent 30 years at Procter & Gamble (P&G), successfully growing and leading several of the company’s multi-billion-dollar businesses. During her tenure with P&G, she also served as Group President and Senior Executive Officer for P&G’s $20 billion Beauty Business, its $20 billion Asian Business, and its $14 billion Baby Care Business. Deb is currently a partner at G100 Companies.

Deb spent seven consecutive years on Fortune’s U.S. and International rankings of the 50 Most Powerful Women in Business.

Daniel Gilcher

Daniel is an investment professional with Shareholder Value Management, a leading independent fund advisor in Germany. He oversees various investments in publicly listed and private businesses across the globe.

Laurence Klein

Laurence previously served as founder and CEO of several award-winning startups. He currently operates a private equity fund, as well as advising and sitting on the boards of various companies.

Dr. Stephen K. Klasko, MD MBA
Strategic Advisor

Dr. Klasko is the President of Thomas Jefferson University and Chief Executive Officer of Jefferson Health. He is a transformative leader and advocate for a revolution in healthcare and higher education. Dr. Klasko is also a published author and highly sought after speaker in the healthcare and business communities.

The Advisory Board

Prof. Simcha Yagel, MD
Medical Advisor

Prof. Yagel is presently the Head of the Division of Obstetrics and Gynecology of Hadassah-Hebrew University Medical Centers, Jerusalem. He has performed a wide range of research in obstetric and gynecological ultrasound.

Dr. Lawrence D. Platt, MD
Medical Advisor

In addition to his private practice work, Dr. Platt is a Clinical Professor in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA.

Dr. Jack Rychik, MD
Medical Advisor

Dr. Rychik is the director of the Fetal Heart Program and Single Ventricle Survivorship Program at the Children’s Hospital of Philadelphia.

Prof. Varda Shalev, MD
Medical Advisor

Prof. Varda Shalev is a family physician and founder of the Department of Medical Informatics and Database Research at Maccabi Healthcare Services.

Prof. Christof Sohn, MD
Medical Advisor

Prof. Sohn is Chairman and Head of the Department for Gynecology and Obstetrics of the University Hospital Heidelberg and Head of the Division for Gynecological Oncology of the National Tumor Center.

Dr. Joseph Hanoch, MD
Medical Advisor

Dr. Hanoch is a Specialist in Obstetrics & Gynecology at Hadassah hospitals and Hebrew University. He is a sub-specialist in gynecological oncology and cervical pathology.

Aileen Stockburger
Business Advisor

Aileen Stockburger is a Strategic Planning and Corporate Transaction Executive. Most recently, she was Worldwide VP of Business Development for the DePuy Synthes Group of Johnson & Johnson.

Dr. Steven Warsof, MD
Business Advisor

Prof. Warsof is on the faculty at Eastern Virginia Medical School’s Division of Maternal Fetal Medicine where he serves as Director of Genetics and Prenatal Diagnosis. He is also a visiting professor at the Bar Ilan University Medical School.

Dr. Joshua Copel, MD
Strategic Advisor

Dr. Copel is Professor, Obstetrics, Gynecology & Reproductive Services, and Pediatrics at Yale School of Medicine. He brings over 30 years of experience to women’s health with a concentration in Obstetrics and Gynecology. He is a past President of American Institute of Ultrasound Medicine and Society for Maternal-Fetal Medicine.

Karen Prange, C-Suite Level MedTech Executive
Strategic Advisor

Ms. Prange brings over 25 years of operating experience in Healthcare. She served as Senior Vice President at Boston Scientific Corporation where she was responsible for leading the Women’s Health business. She also held senior level executive positions at Henry Schein Inc. and Johnson & Johnson Companies.

Why we care

Pregnancy care is outdated and ripe for disruption. Here are some reasons why we are leading the shift from hospital to home.

Pregnancy management
is disruption-ready

  • The high cost of care is unsustainable
  • High-risk pregnancies are more likely due to the rising age of mothers-to-be, high BMI, and growing complications
  • Half of U.S. counties lack a single OB/GYN specialist due to a critical shortage

Existing technology is outdated

  • Pregnancy monitoring, Doppler and CTG, is 30 years old and unchanged
  • Existing solutions have a 35% failure rate for measuring contractions
  • Maternal-fetal data is limited, fragmented, and available only during doctor visits
  • Fails to meet expectations of highly connected millennial parents

Remote monitoring has proved to
reduce costs and improve outcomes

  • Prolonging pregnancy closer to term
  • Higher birth weight
  • Reduced fetal mortality
  • Increased patient satisfaction

Meet us at a conference

Here's where we'll be in 2020. Be sure to say "hello" and join our movement to revolutionize maternity care:

Women’s Health Innovation Summit

September 14-22, 2020, Virtual

Panel Participation: Accelerating Telehealth Panel: Women’s Health Perspectives

September 21st, 12:40 EDT

CB Insights Future of Health Conference

September 23-25, 2020, Virtual

MIT Solve Challenge Finals

September 29, 2020, Virtual

2020 HTLH Conference

October 11-14, 2020 Las Vegas, NV

Join the #MaternityMovement now.

Get updates on what we're doing and how you can help.